Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig03701 |
---NA--- |
295 |
0 |
|
|
0 |
|
|
|
contig03702 |
protein kinase lyk5 |
434 |
20 |
4.04E-64 |
76.20% |
10 |
P:protein heterooligomerization; C:protein complex; P:activation of protein kinase activity; F:protein serine/threonine kinase activity; P:protein export from nucleus; F:protein binding; F:nucleotide binding; C:cytoplasm; C:nucleus; P:protein amino acid phosphorylation |
EC:2.7.11.0 |
|
contig03703 |
---NA--- |
923 |
0 |
|
|
0 |
|
|
|
contig03704 |
damage-specific dna binding protein 2 |
250 |
20 |
2.62E-23 |
84.55% |
9 |
C:protein complex; P:protein autoubiquitination; F:protein binding; P:protein polyubiquitination; F:damaged DNA binding; F:ubiquitin-protein ligase activity; P:nucleotide-excision repair; C:nucleus; P:response to UV |
EC:6.3.2.19 |
|
contig03705 |
serine arginine repetitive matrix 1 |
285 |
20 |
4.03E-35 |
98.15% |
6 |
F:DNA binding; ; C:spliceosomal complex; F:protein binding; C:nuclear matrix; P:nuclear mRNA splicing, via spliceosome |
|
|
contig03706 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig03707 |
---NA--- |
154 |
0 |
|
|
0 |
|
|
|
contig03708 |
---NA--- |
359 |
0 |
|
|
0 |
|
|
|
contig03709 |
arp3 actin-related protein 3 homolog |
130 |
20 |
1.41E-16 |
99.85% |
6 |
F:ATP binding; C:cytoplasm; F:actin binding; C:lamellipodium; C:actin cytoskeleton; F:structural constituent of cytoskeleton |
|
|
contig03710 |
arp3 actin-related protein 3 homolog |
412 |
20 |
2.08E-44 |
100.00% |
6 |
F:ATP binding; C:cytoplasm; F:actin binding; C:lamellipodium; C:actin cytoskeleton; F:structural constituent of cytoskeleton |
|
|
contig03711 |
arp3 actin-related protein 3 homolog |
574 |
20 |
6.05E-62 |
99.10% |
7 |
C:cytoplasm; F:structural constituent of cytoskeleton; P:cellular component movement; C:Arp2/3 protein complex; C:lamellipodium; F:actin binding; F:ATP binding |
|
|
contig03712 |
dna-damage-inducible transcript 4-like |
253 |
1 |
3.55E-15 |
88.00% |
0 |
|
|
|
contig03713 |
swi snf matrix actin dependent regulator of subfamily member isoform 2 |
800 |
2 |
4.03E-04 |
85.00% |
0 |
|
|
|
contig03714 |
---NA--- |
416 |
0 |
|
|
0 |
|
|
|
contig03715 |
---NA--- |
177 |
0 |
|
|
0 |
|
|
|
contig03716 |
solute carrier family 30 (zinc transporter) member 7 |
392 |
20 |
2.54E-34 |
86.30% |
7 |
C:Golgi apparatus; C:cytoplasmic membrane-bounded vesicle; F:protein binding; P:zinc ion transport; C:membrane attack complex; F:zinc ion binding; F:zinc ion transmembrane transporter activity |
|
|
contig03717 |
dihydrouridine synthase 4-like |
560 |
20 |
6.97E-97 |
90.35% |
5 |
P:tryptophan metabolic process; F:FAD binding; F:indole-3-glycerol-phosphate synthase activity; F:tRNA dihydrouridine synthase activity; P:tRNA processing |
EC:4.1.1.48 |
|
contig03718 |
---NA--- |
410 |
0 |
|
|
0 |
|
|
|
contig03719 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig03720 |
progesterone immunomodulatory binding factor 1 |
231 |
20 |
1.38E-11 |
76.55% |
2 |
F:F; C:C |
|
|
contig03721 |
developmentally regulated gtp binding protein 2 |
406 |
20 |
3.23E-45 |
97.80% |
3 |
C:cytoplasm; P:signal transduction; F:GTP binding |
|
|
contig03722 |
---NA--- |
548 |
0 |
|
|
0 |
|
|
|
contig03723 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
contig03724 |
---NA--- |
868 |
0 |
|
|
0 |
|
|
|
contig03725 |
glycyl-trna synthetase |
246 |
20 |
8.19E-25 |
94.20% |
6 |
P:glycyl-tRNA aminoacylation; F:protein binding; P:regulated secretory pathway; F:ATP binding; C:secretory granule; F:glycine-tRNA ligase activity |
EC:6.1.1.14 |
|
contig03726 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig03727 |
---NA--- |
233 |
0 |
|
|
0 |
|
|
|
contig03728 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig03729 |
PREDICTED: wu:fb39e10 [Danio rerio] |
491 |
1 |
2.54E-24 |
80.00% |
0 |
|
|
|
contig03730 |
---NA--- |
680 |
0 |
|
|
0 |
|
|
|
contig03731 |
---NA--- |
280 |
0 |
|
|
0 |
|
|
|
contig03732 |
eukaryotic translation initiation factor subunit 10 |
346 |
20 |
2.43E-32 |
96.50% |
6 |
C:eukaryotic translation initiation factor 3 complex; F:protein binding; P:regulation of translational initiation; F:translation initiation factor activity; C:nucleus; F:structural molecule activity |
|
|
contig03733 |
v-ki-ras2 kirsten rat sarcoma viral oncogene homolog |
418 |
20 |
1.86E-40 |
100.00% |
25 |
C:membrane raft; F:LRR domain binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of NF-kappaB transcription factor activity; P:sensory perception of sound; P:visual learning; P:positive regulation of Rac protein signal transduction; C:membrane fraction; P:regulation of synaptic transmission, GABAergic; P:response to mineralocorticoid stimulus; F:GTP binding; P:striated muscle cell differentiation; P:response to glucocorticoid stimulus; P:negative regulation of neuron apoptosis; P:positive regulation of cell proliferation; C:intracellular; P:positive regulation of MAP kinase activity; P:regulation of cell cycle; F:GMP binding; P:regulation of long-term neuronal synaptic plasticity; P:actin cytoskeleton organization; F:GDP binding; F:GTPase activity; C:plasma membrane; P:cytokine-mediated signaling pathway |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig03734 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig03735 |
---NA--- |
280 |
0 |
|
|
0 |
|
|
|
contig03736 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig03737 |
swi snf matrix actin dependent regulator of subfamily member 1 |
516 |
20 |
6.38E-93 |
93.65% |
12 |
P:regulation of transcription from RNA polymerase II promoter; C:XY body; P:retroviral genome replication; P:negative regulation of cell proliferation; P:cell differentiation; F:protein binding; P:transcription antitermination; C:SWI/SNF complex; P:blastocyst hatching; P:negative regulation of cell cycle; P:DNA integration; P:chromatin remodeling |
|
|
contig03738 |
wd repeat domain 4-like |
265 |
3 |
7.08E-08 |
66.67% |
0 |
|
|
|
contig03739 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
contig03740 |
---NA--- |
1131 |
0 |
|
|
0 |
|
|
|
contig03741 |
rna binding motif protein 28 |
295 |
20 |
1.98E-26 |
84.10% |
3 |
C:nucleus; F:nucleotide binding; F:RNA binding |
|
|
contig03742 |
ribulose-5-phosphate-3-epimerase |
324 |
20 |
1.32E-54 |
94.25% |
3 |
F:protein binding; P:carbohydrate metabolic process; F:ribulose-phosphate 3-epimerase activity |
EC:5.1.3.1 |
|
contig03743 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig03744 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig03745 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig03746 |
---NA--- |
692 |
0 |
|
|
0 |
|
|
|
contig03747 |
unnamed protein product [Tetraodon nigroviridis] |
261 |
1 |
4.61E-07 |
64.00% |
0 |
|
|
|
contig03748 |
---NA--- |
327 |
0 |
|
|
0 |
|
|
|
contig03749 |
glycine c-acetyltransferase |
848 |
20 |
1.28E-99 |
89.60% |
6 |
F:pyridoxal phosphate binding; C:mitochondrial inner membrane; P:cellular amino acid metabolic process; P:biosynthetic process; F:transferase activity, transferring nitrogenous groups; F:glycine C-acetyltransferase activity |
EC:2.3.1.29 |
|
contig03750 |
pb1 protein |
329 |
20 |
6.75E-43 |
96.10% |
0 |
|
|
|
contig03751 |
ribonuclease h2 subunit c |
641 |
20 |
5.13E-53 |
69.65% |
2 |
F:F; C:C |
|
|
contig03752 |
elongation of very long chain fatty acids protein 1 |
181 |
2 |
4.97E-06 |
75.00% |
0 |
|
|
|
contig03753 |
elongation of very long chain fatty acids (fen1 sur4 yeast)-like 1 |
874 |
20 |
1.69E-110 |
84.90% |
4 |
C:endoplasmic reticulum membrane; P:fatty acid biosynthetic process; F:protein binding; C:integral to membrane |
|
|
contig03754 |
elongation of very long chain fatty acids protein 1 |
121 |
10 |
6.19E-12 |
79.00% |
3 |
F:F; C:integral to membrane; P:P |
|
|
contig03755 |
---NA--- |
102 |
0 |
|
|
0 |
|
|
|
contig03756 |
---NA--- |
390 |
0 |
|
|
0 |
|
|
|
contig03757 |
---NA--- |
764 |
0 |
|
|
0 |
|
|
|
contig03758 |
---NA--- |
128 |
0 |
|
|
0 |
|
|
|
contig03759 |
---NA--- |
600 |
0 |
|
|
0 |
|
|
|
contig03760 |
dead (asp-glu-ala-asp) box polypeptide 53 |
259 |
20 |
1.87E-16 |
66.90% |
3 |
F:nucleic acid binding; F:hydrolase activity; F:nucleotide binding |
|
|
contig03761 |
homeodomain transcription factor 2 |
267 |
20 |
2.42E-08 |
100.00% |
4 |
F:DNA binding; C:nucleus; C:endoplasmic reticulum; P:regulation of transcription, DNA-dependent |
|
|
contig03762 |
axin isoform 1 |
279 |
20 |
2.23E-22 |
99.70% |
11 |
C:beta-catenin destruction complex; P:sensory perception of sound; F:signal transducer activity; C:lateral plasma membrane; F:beta-catenin binding; C:cytoplasmic membrane-bounded vesicle; P:protein catabolic process; P:multicellular organismal development; P:negative regulation of Wnt receptor signaling pathway; C:nucleus; C:synapse |
|
|
contig03763 |
uba and wwe domain containing 1 |
348 |
20 |
3.16E-40 |
100.00% |
8 |
C:cytoplasm; P:histone ubiquitination; F:DNA binding; F:protein binding; P:protein polyubiquitination; P:mRNA transport; F:ubiquitin-protein ligase activity; C:nucleus |
EC:6.3.2.19 |
|
contig03764 |
developmentally regulated gtp binding protein 2 |
573 |
20 |
2.39E-42 |
95.40% |
3 |
C:cytoplasm; P:signal transduction; F:GTP binding |
|
|
contig03765 |
---NA--- |
280 |
0 |
|
|
0 |
|
|
|
contig03766 |
cdt1 protein |
446 |
20 |
2.79E-12 |
87.20% |
6 |
P:regulation of S phase of mitotic cell cycle; P:DNA replication checkpoint; C:replication fork; F:DNA binding; F:protein binding; C:nucleus |
|
|
contig03767 |
ring finger protein 4 |
298 |
2 |
5.06E-06 |
83.50% |
0 |
|
|
|
contig03768 |
---NA--- |
305 |
0 |
|
|
0 |
|
|
|
contig03769 |
novel protein mitochondrial translational release factor 1-like |
225 |
3 |
1.30E-17 |
79.00% |
0 |
|
|
|
contig03770 |
---NA--- |
687 |
0 |
|
|
0 |
|
|
|
contig03771 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig03772 |
---NA--- |
441 |
0 |
|
|
0 |
|
|
|
contig03773 |
timeless interacting protein |
269 |
20 |
1.16E-18 |
56.45% |
6 |
P:negative regulation of DNA replication; P:regulation of S phase; P:DNA-dependent DNA replication; P:DNA integrity checkpoint; C:nucleus; P:response to DNA damage stimulus |
|
|
contig03774 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig03775 |
ppig protein |
527 |
20 |
2.80E-75 |
94.10% |
4 |
P:protein folding; C:nuclear speck; C:nuclear matrix; F:peptidyl-prolyl cis-trans isomerase activity |
EC:5.2.1.8 |
|
contig03776 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig03777 |
---NA--- |
247 |
0 |
|
|
0 |
|
|
|
contig03778 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig03779 |
---NA--- |
356 |
0 |
|
|
0 |
|
|
|
contig03780 |
---NA--- |
360 |
0 |
|
|
0 |
|
|
|
contig03781 |
---NA--- |
338 |
0 |
|
|
0 |
|
|
|
contig03782 |
heterogeneous nuclear ribonucleoprotein k |
791 |
20 |
2.00E-80 |
76.75% |
5 |
C:nucleoplasm; F:nucleic acid binding; F:protein binding; C:ribonucleoprotein complex; P:RNA processing |
|
|
contig03783 |
delta 1 |
749 |
20 |
3.74E-62 |
79.70% |
12 |
C:protein complex; C:microtubule; P:spermatogenesis; P:protein polymerization; P:microtubule-based movement; P:cell differentiation; C:centriole; F:GTPase activity; F:structural constituent of cytoskeleton; P:multicellular organismal development; C:nucleus; F:GTP binding |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig03784 |
damage-specific dna binding protein 127kda |
408 |
20 |
1.07E-40 |
98.85% |
6 |
C:cytoplasm; F:protein binding; P:ubiquitin cycle; F:damaged DNA binding; C:nucleus; P:DNA repair |
|
|
contig03785 |
novel protein |
806 |
20 |
6.41E-66 |
87.45% |
0 |
|
|
|
contig03786 |
f-box protein 43 |
1064 |
20 |
6.28E-23 |
47.45% |
7 |
F:metal ion binding; F:F; P:P; F:zinc ion binding; P:ubiquitin cycle; P:meiosis; C:C |
|
|
contig03787 |
---NA--- |
366 |
0 |
|
|
0 |
|
|
|
contig03788 |
adenylosuccinate synthase |
351 |
20 |
5.02E-43 |
93.10% |
5 |
C:cytoplasm; F:adenylosuccinate synthase activity; F:GTP binding; P:AMP biosynthetic process; F:magnesium ion binding |
EC:6.3.4.4 |
|
contig03789 |
---NA--- |
471 |
0 |
|
|
0 |
|
|
|
contig03790 |
rna methyltransferase like 1 |
301 |
18 |
4.39E-18 |
61.67% |
2 |
F:RNA methyltransferase activity; P:RNA processing |
|
|
contig03791 |
---NA--- |
666 |
0 |
|
|
0 |
|
|
|
contig03792 |
---NA--- |
319 |
0 |
|
|
0 |
|
|
|
contig03793 |
---NA--- |
443 |
0 |
|
|
0 |
|
|
|
contig03794 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig03795 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig03796 |
novel protein |
779 |
20 |
4.84E-31 |
78.90% |
0 |
|
|
|
contig03797 |
nuclear receptor subfamily group member 1 |
487 |
20 |
1.15E-74 |
89.65% |
9 |
; F:sequence-specific DNA binding; F:steroid hormone receptor activity; F:transcription factor activity; F:steroid binding; P:negative regulation of transcription from RNA polymerase II promoter; C:nucleus; F:zinc ion binding; F:transcription repressor activity |
|
|
contig03798 |
unnamed protein product [Tetraodon nigroviridis] |
698 |
1 |
1.63E-05 |
98.00% |
0 |
|
|
|
contig03799 |
nucleoporin 62kda |
241 |
20 |
7.73E-15 |
92.50% |
25 |
P:negative regulation of epidermal growth factor receptor signaling pathway; F:thyroid hormone receptor binding; F:transcription regulator activity; P:positive regulation of transcription; P:mRNA transport; F:PTB domain binding; P:intracellular protein transmembrane transport; P:negative regulation of MAP kinase activity; P:negative regulation of Ras protein signal transduction; F:receptor signaling complex scaffold activity; F:ubiquitin binding; C:cytoplasm; P:negative regulation of cell proliferation; F:SH2 domain binding; F:nucleocytoplasmic transporter activity; C:nuclear pore; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; F:protein serine/threonine kinase activity; P:hormone-mediated signaling pathway; C:nucleocytoplasmic shuttling complex; P:positive regulation of epidermal growth factor receptor signaling pathway; ; F:structural constituent of nuclear pore; F:chromatin binding; P:negative regulation of apoptosis |
EC:2.7.11.0 |
|
contig03800 |
insulin-degrading enzyme |
234 |
20 |
1.16E-34 |
97.00% |
9 |
C:soluble fraction; C:extracellular space; F:signal transducer activity; C:peroxisome; P:sex differentiation; P:signal transduction; F:insulysin activity; P:proteolysis; F:zinc ion binding |
EC:3.4.24.56 |
|
100 Rows returned.